P
Philippe Maingon
Researcher at University of Paris
Publications - 261
Citations - 17363
Philippe Maingon is an academic researcher from University of Paris. The author has contributed to research in topics: Radiation therapy & Prostate cancer. The author has an hindex of 49, co-authored 238 publications receiving 14930 citations. Previous affiliations of Philippe Maingon include European Organisation for Research and Treatment of Cancer & Radboud University Nijmegen.
Papers
More filters
Journal ArticleDOI
Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population‐based study
Tienhan Sandrine Dabakuyo,A. Arnaud,Philippe Maingon,S. Causeret,Bruno Coudert,P. Fumoleau,Laurent Arnould,Marie-Laure Poillot,Patrick Arveux,Gilles Créhange,F. Bonnetain +10 more
TL;DR: This population-based study aimed to describe the effects of neoadjuvant chemotherapy (NC) on survival in breast cancer patients in daily practice and found that the use of NC did not independently influence RS.
Journal ArticleDOI
[Update regarding the management of vulvar cancer: The guidelines of the Assistance Publique-Hôpitaux de Paris].
Henri Azaïs,Victoire Pauphilet,Jérémie Belghiti,Maryam Nikpayam,Clémentine Gonthier,Philippe Maingon,Rosa Conforti,Catherine Uzan,Geoffroy Canlorbe,Groupe transversal sein-gynécologie Ap–Hp +9 more
TL;DR: La radiotherapie est indiquee en cas d’atteinte ganglionnaire ou en situation neoadjuvante si the tumeur n’est pas resecable d‘emblee, mais la radiotherAPie et the chimiotherapies ont pris une place plus importante au cours des dernieres annees.
Journal ArticleDOI
Combining sirolimus-eluting stents and external irradiation in cholesterol-fed rabbits increased incomplete stent apposition and decreased re-endothelialization.
David Busseuil,Bertrand Collin,Gilles Rioufol,Claudia Korandji,Marianne Zeller,Philippe Maingon,François Briot,Yves Cottin,Luc Rochette +8 more
TL;DR: It is revealed that low-dose external irradiation increased incomplete stent apposition and reduced re-endothelialization of SES and the potential deleterious cumulative side effects of these 2 procedures to prevent restenosis.
Journal ArticleDOI
Treatment related factors associated with the risk of breast radio-induced-sarcoma.
Céline Mirjolet,Ibrahima Diallo,Aurélie Bertaut,Cristina Veres,Paul Sargos,Sylvie Helfre,Marie-Pierre Sunyach,Gilles Truc,Cécile Le Péchoux,Amaury Paumier,Anne Ducassou,Maria Jolnerovski,Juliette Thariat,Michel Lapeyre,A. Cordoba,Marc-André Mahé,Philippe Maingon +16 more
TL;DR: In this article , the authors used patient-representative voxel-based anthropomorphic phantoms to reconstruct patient-specific RT fields for 125 patients diagnosed with RIS after primary breast cancer.
Journal ArticleDOI
Impact of p16 expression on induction taxotere-cisplatin-5 FU (TPF) followed by cetuximab-radiotherapy in N2b-N3 head and neck squamous cell carcinoma (HNSCC): Results of GORTEC 2007-02 phase III randomized trial.
Yungan Tao,Lionnel Geoffrois,Laurent Martin,Dominique De Raucourt,Joelle Miny,Philippe Maingon,Cedrik Lafond,C. Tuchais,Christian Sire,Emmanuel Babin,Alexandre Coutte,Frederic Rolland,Marie-Helene Girard-Calais,Odile Casiraghi,Pascal Garaud,Jean Bourhis +15 more
TL;DR: TPF is a reference induction chemotherapy regimen in non-operated locally advanced (LA) HNSCC and GORTEC 2007-02 phase III randomized trial was restricted to H NSCC patients with large numbers of patients needing treatment with TPF.